-
Je něco špatně v tomto záznamu ?
Gestační diabetes - modelová studie. (Vliv aloxanového diabetu na spektrum mastných kyselin v krevním séru, v játrech a v mozku u laboratorního potkana)
[Gestational diabetes - model trial]
J. Mourek, L. Šmídová, V. Šlapetová
Jazyk čeština Země Česko
Grantová podpora
IZ3293
MZ0
CEP - Centrální evidence projektů
- MeSH
- gestační diabetes patologie MeSH
- krysa rodu rattus MeSH
- modely nemocí na zvířatech MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
In alloxan-induced diabetic rats (Wistar, females, age 3-4 months of postnatal life) the large spectrum of fatty acids in blood serum, brain cortex, medulla oblongata and liver was studied. The fatty acids, using gas chromatography, were detected as methyl esters and the methods were published previously (Šmídová and al. 1994). Alloxan (Merck) administered i.p., 140 mg/kg body weight, caused immediately elevation (three times) of blood sugar levels. On the 13th day the rats were killed. The results are as follows: a) In blood serum alloxan diabetes of cca two weeks duration caused a significantly increased participation of saturated FA and decreased participation of both polyunsaturated FA (n-3 and n-6). b) In brain cortex no differences between controls and diabetic rats in the indicated groups of FA were found. c) In the medulla oblongata an increased participation of polyunsaturated fatty acids n-6 was established. d) In hepatic tissue the increased participation of saturated FA as well as a decreased participation of FA n-6 was described. Analysing the main groups of FA we found especially in n-3 and n-6 FA several significant changes in single FA (a smaller pool of arachidonic acid in blood serum as well as in liver, decreased participation of docosahexaenoic acid in the brain cortex, etc.). The purpose and possible consequences of such changes are discussed.
Gestational diabetes - model trial
Gestační diabetes - modelová studie. (Vliv aloxanového diabetu na spektrum mastných kyselin v krevním séru, v játrech a v mozku u laboratorního potkana) = Gestational diabetes - model trial /
Lit: 27
Bibliografie atd.Souhrn en
- 000
- 00000naa a2200000 a 4500
- 001
- bmc98014302
- 003
- CZ-PrNML
- 005
- 20211118103312.0
- 008
- 980900s1998 xr u cze||
- 009
- AR
- 035 __
- $a (PubMed)9750381
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Mourek, Jindřich, $d 1928- $4 aut $7 jk01082206
- 245 10
- $a Gestační diabetes - modelová studie. (Vliv aloxanového diabetu na spektrum mastných kyselin v krevním séru, v játrech a v mozku u laboratorního potkana) = $b Gestational diabetes - model trial / $c J. Mourek, L. Šmídová, V. Šlapetová
- 246 11
- $a Gestational diabetes - model trial
- 314 __
- $a UK. 1. LF. Fyziologický ústav, Praha, CZ
- 504 __
- $a Lit: 27
- 504 __
- $a Souhrn en
- 520 9_
- $a In alloxan-induced diabetic rats (Wistar, females, age 3-4 months of postnatal life) the large spectrum of fatty acids in blood serum, brain cortex, medulla oblongata and liver was studied. The fatty acids, using gas chromatography, were detected as methyl esters and the methods were published previously (Šmídová and al. 1994). Alloxan (Merck) administered i.p., 140 mg/kg body weight, caused immediately elevation (three times) of blood sugar levels. On the 13th day the rats were killed. The results are as follows: a) In blood serum alloxan diabetes of cca two weeks duration caused a significantly increased participation of saturated FA and decreased participation of both polyunsaturated FA (n-3 and n-6). b) In brain cortex no differences between controls and diabetic rats in the indicated groups of FA were found. c) In the medulla oblongata an increased participation of polyunsaturated fatty acids n-6 was established. d) In hepatic tissue the increased participation of saturated FA as well as a decreased participation of FA n-6 was described. Analysing the main groups of FA we found especially in n-3 and n-6 FA several significant changes in single FA (a smaller pool of arachidonic acid in blood serum as well as in liver, decreased participation of docosahexaenoic acid in the brain cortex, etc.). The purpose and possible consequences of such changes are discussed.
- 650 _2
- $a gestační diabetes $x patologie $7 D016640
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 700 1_
- $a Šmídová, L. $4 aut
- 700 1_
- $a Šlapetová, V. $4 aut
- 700 1_
- $a Krejčí, V. $4 aut
- 700 1_
- $a Plavka, Richard, $d 1957- $4 aut $7 xx0084863
- 773 0_
- $w MED00010981 $t Česká gynekologie $g Roč. 63, č. 3 (1998), s. 202-206 $x 1210-7832
- 910 __
- $a ABA008 $b A 4086 $c 310 $y 0 $z 0
- 990 __
- $a 20060602 $b ABA008
- 991 __
- $a 20211118103314 $b ABA008
- BAS __
- $a 3
- BMC __
- $a 1998 $b Roč. 63 $c č. 3 $d s. 202-206 $i 1210-7832 $m Česká gynekologie $x MED00010981
- GRA __
- $a IZ3293 $p MZ0
- LZP __
- $b přidání abstraktu